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Oligomeric substances in ampicillin
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Summary
An investigation into the presence of potentially
harmful oligomers in formulations of ampicillin for
parenteral administration available in the RSA was
undertaken by means of high-pressure liquid chroma-
tography. Significant differences were found.to exist
between formulations.
S Afr Med J 1988; 73: 453-455.
It is known that ampicillin sodium in aqueous solution under-
goes a self-aminolytic degradation reaction to produce a dimer,
followed by the formation of oligomers of higher molecular
weight. 1- 3 Since these oligomerisation products of ampicillin
have been reported to possess strong antigenic properties in
animals,4-7 it has been recommended that their presence in
clinically used ampicillin preparations be limited to the lowest
possible leve1.2
During in vivo ampicillin-gentamicin interaction studies
undertaken by our group, it was observed during high-pressure
liquid chromatographic (HPLC) analysis that, in addition to the
parent ampicillin, various other oligomeric peaks were also
present. These complicated interpretation of the results of the
interaction studies in animals. Since ampicillin dimer is the
major initial oligomer peak it was decided to determine the ratio
of peak areas of ampicillin to dimer in solutions of Famicillin,
Penbritin and Petercillin. Freshly prepared solutions
were compared immediately after reconstitution, as well as over a
time course of 8 hours to investigate possible differences.
Methods
2 J.Ll was taken, and added to 250 J.Ll water and 375 J.Ll solvent
diluent within 30 seconds and vortexed. From this final mixture
500 J.Ll, containing approximately 32 J.Lg ampicillin, was drawn up
in a HPLC syringe and injected onto the extraction column of a
Hewlett-Packard 1090 L liquid chromatograph. The apparatus
was equipped with an autosampler and a manual injection valve
system and was coupled to a Hewlett-Packard 3392 reporting
integrator. Separation of components was effected on a Whatman
Partesil 5 ODS-C8 25 cm column at 50°C, using an eluent
consisting of a phosphate buffer, in a gradient from 10% to 70%,
and an acetonitrile/isopropanol mixture, over a time course of 20
minutes. Flow rate was maintained at 1,5 ml/min and components
in the column effluent were detected photometrically at 230 nm
by means of the built-in photometric detector of the liquid
chromatograph. Prazepam (100 ng) was used as internal standard
to monitor the consistency of the HPLC method.
Time course studies were also performed on a sample from each
of the batches of Famicillin, Penbritin and Petercillin. Procedures
followed were exactly the same as described above except that
aliquots of the initial mixture of the ampicillin of 500 mgl2,5 ml
or 250 mg/l,25 ml were removed and analysed at 3 and 30
minutes and at 1, 1,5,2,3,4,6 and 8 hours, respectively.
In order to positively identify ampicillin and ampicillin dimer in
the solutions, a split-effluent technique was used and samples
eluted from the HPLC column were collected and freeze-dried.
CWorofonn extraction of these residues yielded samples which
were analysed by probe-insertion mass spectrometry and by DV
speetroscopy. In addition, the antibacterial activity in cultures of
Escherichia coli of each of these two substances was determined.
Srudent's (-test was used in the statistical analysis of the results.
Results
Peaks A, B and C in Fig. 1 indicate ampicillin, ampicillin dimer
and prazepam internal standard respectively. Peaks occuning at
retention times of 3,3 minutes and less are solvent and injection
peaks and are method-related, as are those occurring after peak C.
Other peaks are probably due to higher oligomers and impurities.
Table I gives information on the batch numbers and the expiry
dates of the ampicillin products analysed.
TABLE I. PRODUCT INFORMATION ON
SAMPLES ANALYSED





Vials containing 500 mg and 250 mg ampicillin from each of four
different batches ofFamicillin and each ofthree different batches of
Penbritin and Petercillin were examined.
HPLC grade distilled water (2,5 ml or 1,25 ml) was added to to
each vial and the contents dissolved by shaking vigorously for 3
minutes. Immediately after this a 100 J.Ll aliquot of the solution
was made up to 1 ml with water and vortexed. From this solution
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Fig. 3. Curves showing the decreases in the ratio A/B with time
for a randomly selected sample of Petercillin (batch No. 201045),
Penbritin (batch No. 102971) and Famicillin (batch No. 802116),
where A = area under the curve for ampicillin and B = area
under the curve for ampicillin diiner.
Fig. 3. shows the decreases found in the ratios NB over a
period of 8 hours after reconstitution of samples, .taken from
batches of Petercillin, Penbririn and Farnicillin.
Material collected by the split-effluent HPLC technique from
peaks A and B (Fig. 1) and analysed by UV spectroscopy and
mass spectrometry confirmed that peak A corresponded to ampi-
cillin and peak B to ampicillin dimer. While ampicillin showed the
usual zone of inhibition of growth of E. coli in cultures, no such
inhibition could be observed for the ampicillin dimer.
Average ratios of areas under the curves A and B (Fig. 1)
determined 3 minutes after reconstitution for the various batches
of ampicillin (Table I) are shown in Fig. 2. While no significant
differences could be shown between these ratios for Petercillin and
Penbritin both these differed significantly (P < 0,0005) from the
ratio NB for Famicillin.
Fig. 1. Top: Representative high-pressure liquid chromatogram
obtained for freshly prepared Penbritin. Peak A = ampicillin,
peak B = ampicillin dimer and peak C = internal standard
(prazepam). Bottom: Representative high-pressure liquid chroma-
togram obtained for freshly prepared Famicillin. Peak A = ampi-
cillin, peak B = ampicillin dimer and peak C = internal standard
(prazepam).
Discussion
Since oligomer formation in aqueous solution of ampicillin
(10% w/v) is rapid, samples for HPLC analysis for oligomeric
substances should be injected within 5 minutes of dissolution.2
In our study 20% (w/v) aqueous solutions of ampicillin were
used and only 3 minutes were accordingly allowed for the
dissolution step as it is evident from Fig. 3 that dimers form
quickly at these concentrations.
It is evident from Fig. 2 that 3 minutes after dissolution,
Famicillin contained a ratio of ampicillin to ampicillin dimer .
at least 5 times 10weJ:" than that of Penbritin or Petercillin.
Similarly, the ratio of ampicillin to its dimer was twice as high
in Penbritin and Petercillin relative to Famicillin for the first
30 minutes after reconstitution of a vial taken randomly from
each of the batches of the three different ampicillin formu-
lations.
It has been clearly shown in the present study that the
content of potentially harmful oligomeric substances in generi-
cally equivalent parenteral ampicillins available in the RSA
may vary considerably. Although no limits have as yet been
placed on the content of these substances it would seem
prudent to do so.
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and Ms H. van der Straaten, Department of Chemistry, University














Fig. 2. Average ratio A/B determined 3 minutes after reconstitution
for various batches of Petercillin (N = 3), Penbritin (N = 3) and
Famicillin (N = 4), where A = area under the curve of ampicillin
and B = area under the curve for ampicillin dimer.
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AIDS and South Africa
comprehensive strategy.
- towards a
Part I. The world-wide experience
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Summary
In this, the first of a three-part series of articles in
which we propose steps towards a comprehensive
strategy for the control of HIV infection, we consider
briefly the world-wide experience with the HIV epi-
demic. Our objective is to highlight the problems and
controversial issues which are pertinent to strategies
for the control of HIV infection. We focus on problems
of case-definition, differences between 'African' and
'Western' AIDS and the implications for South Africa,
and problems with sensitivity and specificity of tests
used at present, particularly in the context of false
positivity in a community with a low prevalence of
HIV infection. We consider some of the ethical issues,
including the need for adequate· counselling, the
need for informed consent before testing, and the
centrality of confidentiality, particularly in the context
of possible victimisation and neglect of HIV-positive
individuals. Differences between 'notification' and
'reporting' are emphasised. Recommendations are
made regarding these problems.
S AIr Med J 1988; 73: 455-460.
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The objective of these three articles is to focus on the contro-
versies and issues that are central to an effective comprehensive
strategy for the control of HIV infection and AIDS in South
Mrica and to make recommendations based on our deliberations
and reading. These articles are not a review of reports about
AIDS but rather a synthesis of ·those reports in a quest for
some of the answers to successful control. For example, the
clinical spectrum of HIV infection and its treatment are not
considered because they have received adequate attention else-
where. I-3 Furthermore, little attention is given to the detailed
but limited epidemiological information available, and hence
health service planning, which has an adequate database as a
prerequisite,4,5 is not discussed.
This article has been prepared by a large group, but the
authorship does not yet adequately reflect the spectrum of
opinion that needs to be involved in the formulation of an
AIDS strategy in South Mrica. We have made recommenda-
tions largely based on consensus, but there were occasions
when one or other member of the group would allow a
recommendation to be made despite strong personal opinion
against it. This exercise in seeking the common path has
further convinced us of the need for a multidisciplinary AIDS
group to meet the brief spelled out in the latter pages of these
articles.
